Pediatric Autoimmune Diseases: Molecular Basis and Therapy

Dear Colleagues,

Until recently, our understanding of pediatric autoimmune diseases was limited, creating a significant gap between the complexity of these disorders and our knowledge of their causes. This gap hindered our ability to effectively treat many patients. Treatments typically relied on broad immunosuppressive medications like steroids, which often led to a range of side effects and sometimes provided insufficient relief.

Recognizing the importance of understanding the molecular basis of these diseases, recent years have seen significant progress in this area. This progress has paved the way for the development of targeted therapies tailored to the individual needs of the patient. Precision medicine, including genetic testing and biomarker analysis, shows promise in improving treatment outcomes while minimizing side effects.

The advancements in this field are both exciting and rapid. To encourage further research and innovation, we have initiated this Special Issue. Our goal is to inspire researchers in this dynamic field to share their findings. We hope that this topic will spark interest and lead to the publication of numerous research papers, ultimately advancing our understanding and treatment of pediatric autoimmune diseases.

Prof. Dr. Marija Jelusic
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• autoimmunity
• immune regulation
• biomarker analysis
• molecular pathways
• precision medicine
• genetics